Not applicableWithdrawnNCT04261556What this trial is testingTDCS to Enhance Cognitive Training in Multiple SclerosisWho this might be right forMultiple Sclerosis, Relapsing-Remitting University of Milano Bicocca
Early research (Phase 1)Study completedNCT02193217What this trial is testingExplore the Cardiac Pharmacodynamics of MT-1303Who this might be right forRelapsing-remitting Multiple Sclerosis Tanabe Pharma Corporation 81
Testing effectiveness (Phase 2)Ended earlyNCT00595920What this trial is testingOpen Label Extension of Prior TERMS Study to Treat Relapsing Forms of Multiple SclerosisWho this might be right forMultiple Sclerosis, Relapsing-RemittingClinically Isolated Syndrome Opexa Therapeutics, Inc. 116
Large-scale testing (Phase 3)Study completedNCT01462318What this trial is testingAn Open-Label Immunogenicity and Pharmacokinetics Study of Daclizumab High Yield Process Prefilled Syringe in Relapsing Remitting Multiple SclerosisWho this might be right forRelapsing-Remitting Multiple Sclerosis Biogen 133
Post-approval studies (Phase 4)Study completedNCT01930708What this trial is testingA Study Evaluating the Effectiveness of Tecfidera (Dimethyl Fumarate) on Multiple Sclerosis (MS) Disease Activity and Patient-Reported OutcomesWho this might be right forRelapsing-Remitting Multiple SclerosisMultiple Sclerosis Biogen 1,114
Not applicableStudy completedNCT05218317What this trial is testingEvaluation of Relapse Presence in Multiple SclerosisWho this might be right forMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis Relapse Marmara University 87
Testing effectiveness (Phase 2)Study completedNCT01433250What this trial is testingEvaluate the Safety, Tolerability and Efficacy of AIN457 in Patients With Relapsing-remitting Multiple SclerosisWho this might be right forMultiple Sclerosis Novartis Pharmaceuticals 39
Post-approval studies (Phase 4)Study completedNCT02419378What this trial is testingAlemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective PotentialWho this might be right forMultiple Sclerosis, Relapsing-Remitting University Hospital Muenster 15
Not applicableStudy completedNCT07000968What this trial is testingThe Effect of Task-Oriented Training and Virtual Reality Training on Balance, Gait and Fatigue in Individuals With Multiple SclerosisWho this might be right forMultiple SclerosisBalance Impairment, Gait Disorders, FatigueMultiple Sclerosis Bening+1 more Inonu University 63
Not applicableStudy completedNCT01925690What this trial is testingDevelopment of a Motivational Intervention to Improve Treatment Adherence in MSWho this might be right forRelapsing-remitting Multiple Sclerosis University of Missouri, Kansas City 80
Testing effectiveness (Phase 2)Study completedNCT01450124What this trial is testingSafety, Tolerability And Mechanism Of Action Of Boswellic Acids (BA) In Multiple Sclerosis (SABA)Who this might be right forRelapsing Remitting Multiple Sclerosis Universitätsklinikum Hamburg-Eppendorf 29
Not applicableStudy completedNCT02308670What this trial is testingEvaluate the Effect of Switching From Daily Injections of 20mg Glatiramer Acetate (GA) to 40mg GA Three Times a Week in Subjects With Relapsing-remitting Multiple SclerosisWho this might be right forMultiple Sclerosis University at Buffalo 150
Post-approval studies (Phase 4)Study completedNCT02205489What this trial is testingManagement Of The Infusion-Associated Reactions In RRMS Patients Treated With LEMTRADAWho this might be right forRelapsing-remitting Multiple Sclerosis Genzyme, a Sanofi Company 58
Not applicableLooking for participantsNCT04604041What this trial is testingInvestigation of Subclinical Markers of Multiple SclerosisWho this might be right forMultiple SclerosisRelapsing Remitting Multiple Sclerosis University of Split, School of Medicine 50
Not applicableStudy completedNCT01485003What this trial is testingObservational Study of Tysabri in Early Relapsing-Remitting Multiple Sclerosis in Anti-JC Virus Antibody Negative ParticipantsWho this might be right forRelapsing-Remitting Multiple Sclerosis Biogen 231
Not applicableNot Yet RecruitingNCT07724093What this trial is testingEffects of Powered Hip Flexion Device in Persons With Multiple SclerosisWho this might be right forMultiple Sclerosis (MS) Relapsing Remitting University of Dayton 10
Early research (Phase 1)Ended earlyNCT01318421What this trial is testingELND002 in Patients With Relapsing Forms of Multiple SclerosisWho this might be right forMultiple Sclerosis Elan Pharmaceuticals 12
Large-scale testing (Phase 3)Study completedNCT02579681What this trial is testingStudy Assessing Cognition in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Treated With BG00012Who this might be right forMultiple Sclerosis, Relapsing-Remitting Biogen 221
Post-approval studies (Phase 4)Study completedNCT00315367What this trial is testingA fMRI(Functional Magnetic Resonance Imaging) Research Study to Learn More About Multiple Sclerosis and Individuals Potentially Experiencing Memory DifficultiesWho this might be right forRelapsing-Remitting Multiple Sclerosis Neurognostics 26
Large-scale testing (Phase 3)Study completedNCT00306592What this trial is testingNatalizumab Re-Initiation of DosingWho this might be right forMultiple Sclerosis, Relapsing-Remitting Biogen 404